The developed npGG particles within this work presented a size of approximately 140 nm and a round morphology which has been shown to condition nanoparticles to ECM entrapment and restrict their circulation to lymph nodes [46], particularly suiting this current application since tumor-specific CD8 T cells are activated in the tumor-draining lymph nodes. This evidence concerns the gene CD8A and neoplasm.